CINECA IRIS Institutional Research Information System

DANESI, ROMANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 49.098
AS - Asia 20.847
EU - Europa 18.758
SA - Sud America 3.096
AF - Africa 766
OC - Oceania 62
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 92.647
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 47.883
SG - Singapore 6.427
CN - Cina 5.596
IT - Italia 4.613
FI - Finlandia 4.445
HK - Hong Kong 3.836
BR - Brasile 2.588
SE - Svezia 2.389
VN - Vietnam 1.635
DE - Germania 1.557
BG - Bulgaria 1.382
GB - Regno Unito 1.025
CA - Canada 930
TR - Turchia 903
FR - Francia 816
RU - Federazione Russa 666
UA - Ucraina 642
KR - Corea 507
IN - India 423
JP - Giappone 366
CI - Costa d'Avorio 261
CH - Svizzera 236
BD - Bangladesh 216
AT - Austria 182
AR - Argentina 176
NL - Olanda 138
MX - Messico 129
BE - Belgio 122
ZA - Sudafrica 112
PL - Polonia 109
ID - Indonesia 105
IQ - Iraq 105
GR - Grecia 102
SA - Arabia Saudita 95
PK - Pakistan 94
ES - Italia 84
SN - Senegal 78
CO - Colombia 72
NG - Nigeria 69
UZ - Uzbekistan 67
EC - Ecuador 61
VE - Venezuela 60
MA - Marocco 57
AU - Australia 52
PH - Filippine 48
MY - Malesia 46
EG - Egitto 43
PY - Paraguay 42
CL - Cile 40
AE - Emirati Arabi Uniti 39
JO - Giordania 37
TH - Thailandia 37
IE - Irlanda 35
TT - Trinidad e Tobago 32
TW - Taiwan 32
KE - Kenya 30
CZ - Repubblica Ceca 29
IL - Israele 27
TN - Tunisia 27
LT - Lituania 26
NP - Nepal 26
IR - Iran 25
RO - Romania 23
UY - Uruguay 23
HU - Ungheria 22
AZ - Azerbaigian 19
JM - Giamaica 19
CR - Costa Rica 18
DO - Repubblica Dominicana 18
DZ - Algeria 18
OM - Oman 18
BO - Bolivia 17
DK - Danimarca 17
LB - Libano 16
EU - Europa 15
BJ - Benin 14
PE - Perù 14
PT - Portogallo 14
BB - Barbados 13
PS - Palestinian Territory 13
AL - Albania 12
KZ - Kazakistan 12
PA - Panama 12
RS - Serbia 11
BY - Bielorussia 10
HR - Croazia 10
ET - Etiopia 9
HN - Honduras 9
KG - Kirghizistan 9
BH - Bahrain 8
LK - Sri Lanka 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
SV - El Salvador 8
GH - Ghana 7
NI - Nicaragua 7
AM - Armenia 6
BA - Bosnia-Erzegovina 6
BW - Botswana 6
CG - Congo 6
Totale 92.515
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.733
Ashburn 4.592
Fairfield 4.242
Ann Arbor 4.203
Houston 4.001
Helsinki 3.874
Hong Kong 3.782
Singapore 3.493
Chandler 2.444
Santa Clara 2.055
Dallas 1.913
San Jose 1.824
Seattle 1.790
Wilmington 1.511
Cambridge 1.449
Sofia 1.378
Shanghai 1.269
Serra 1.079
Beijing 1.072
Milan 1.029
New York 950
Jacksonville 775
Ottawa 740
Boardman 724
Hefei 639
Princeton 620
Lawrence 562
Izmir 551
Los Angeles 548
Lauterbourg 515
Medford 508
Seoul 478
Nanjing 452
Ho Chi Minh City 367
Dearborn 361
Des Moines 334
Tokyo 302
London 291
Hanoi 277
Abidjan 261
Council Bluffs 256
Istanbul 252
Dong Ket 236
The Dalles 236
Pisa 231
Columbus 228
San Diego 224
Buffalo 219
São Paulo 212
Florence 211
Bern 207
Redondo Beach 201
Munich 183
Frankfurt am Main 179
Nanchang 174
Boulder 159
Vienna 149
Redwood City 144
Rome 142
Falls Church 129
Washington 128
Jüchen 126
Kunming 117
Brussels 110
Bremen 90
Ogden 90
Hebei 86
Rio de Janeiro 84
Chicago 83
Warsaw 83
Düsseldorf 82
Dakar 78
Shenyang 78
Belo Horizonte 77
Changsha 77
Turku 74
Lagos 67
Pune 67
Norwalk 65
Nuremberg 63
Da Nang 61
Phoenix 59
Tashkent 59
Jiaxing 57
Tianjin 56
Toronto 55
Guangzhou 53
Dhaka 52
Orem 51
Fuzhou 50
Stockholm 48
Brasília 47
Johannesburg 46
San Francisco 45
Jakarta 44
Montreal 43
Mumbai 42
Haiphong 41
Riyadh 41
Turin 41
Totale 69.676
Salva come PNG Salva come JPEG
Nome #
Fructose-1,6-diphosphate reduces acute ECG changes due to doxorubicin in isolated rat heart 2.067
The influence of amrinone on cardiac toxicity induced by adriamycin in rats 2.028
Pharmacogenomics in non-small-cell lung cancer chemotherapy 620
Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer 448
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity 353
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 323
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab. 298
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer 288
Exogenous doxorubicinol induces cardiotoxic effects in rats 283
Procedimento attuato per mezzo di un elaboratore per la determinazione dei tempi di ritenzione e dei valori di concentrazione di analiti in una miscela 281
Determination of mitotane and principal metabolite by a simple HPLC-UV method and its validation in human plasma sample 277
A rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasma 273
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 267
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference LC-MS/MS 264
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration 255
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers 249
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 247
Gender, MGMT methylation, and levetiracetam plasma levels correlate with survival benefit in glioblastoma patients treated with adjuvant temozolomide: results from a non-interventional retrospective clinical study 246
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. 243
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 242
First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study 240
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 239
A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties 238
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. 235
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia 233
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 228
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 226
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 225
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients 223
In vitro studies on gemcitabine combinations with other antiblastics 219
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer 219
Suramin, a novel antitumor compound 218
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 217
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference Mass Spectrometry 217
Determination of mitotane and metabolite by a simple HPLC-UV method and application in plasma samples 216
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients 213
Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature. 212
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 212
The effect of rhGM-CSF on the proliferation of osteogenic sarcoma cells 210
Pharmacogenetics in Oncology 210
A pilot study of suramin in the treatment of metastatic renal cell carcinoma 209
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 209
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC 209
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors 208
5-Fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer 208
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer 207
Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life 207
Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment 206
The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. 206
Doxorubicin cardiotoxicity in the dog: A morphofunctional study 205
Periodontal tissue disposition of azithromycin 205
4'-Epidoxorubicin cardiotoxicity 204
Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity 204
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 203
Pharmacokinetics and tolerance of nicotinamide combined with radiation therapy in patients with glioblastoma multiforme 202
A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer 202
Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors 201
Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. 201
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients 201
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. 200
General and cardiac toxicity of adriamycinol in rats 199
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition 199
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 199
Cancer stem cell epigenetics and chemoresistance 198
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients 198
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 198
The effects of the somatostatin analog octreotide on angiogenesis in vitro 197
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 196
Doxorubicin modifies plasma levels of immunoreactive atrial natriuretic factor 195
Impact of locoregional approaches to liver metastases in patients with colorectal cancer 194
5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients 194
Linezolid in the central nervous system: Comparison between cerebrospinal fluid and plasma pharmacokinetics 194
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 194
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy 194
DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis. 194
Molecular basis of resistance to azole antifungals. 193
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 193
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 193
Chronic administration of suramin induces neurotoxicity in rats 192
Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors 192
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 192
Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients 192
Lung tissue penetration and plasma pharmacokinetics of azithromycin after multiple oral doses of 500 and 1000 mg in adults 191
CYP2D6 polymorphisms and the impact on tamoxifen therapy 191
An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw 191
Methods: For studying pharmacogenetic profiles of combination chemotherapeutic drugs 191
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer 191
PERIODONTAL TISSUE DISTRIBUTION OF CEFPODOXIME PROXETIL AND EFFICACY IN ACUTE ODONTOGENIC INFECTIONS 190
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. 190
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 190
Embryonic stem cell pathways and chemotherapy response: an unexplored route. 189
A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma 188
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 188
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine 188
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane 187
The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization 187
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 187
Appropriateness of repetitive therapeutic drug monitoring and laboratory turn around time 187
Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction 186
Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin 186
Totale 25.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 250.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 250.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.066 0 0 0 0 0 0 0 0 0 0 333 733
2021/20226.446 150 395 247 391 1.027 1.006 228 332 262 244 347 1.817
2022/20237.336 1.005 840 474 693 833 1.022 61 565 1.253 48 478 64
2023/20245.397 658 583 710 326 747 1.031 150 263 91 111 183 544
2024/202517.549 112 680 122 965 1.702 1.795 1.332 1.063 1.794 2.287 1.962 3.735
2025/202621.638 1.228 2.950 2.339 1.717 1.745 1.675 2.737 895 4.714 1.416 222 0
Totale 93.776